Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial (Q36467826)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial |
scientific article |
Statements
1 reference
Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial (English)
1 reference
Lai CL
1 reference
Wu PC
1 reference
Lok AS
1 reference
Lin HJ
1 reference
Ngan H
1 reference
Lau JY
1 reference
Chung HT
1 reference
Ng MM
1 reference
Yeoh EK
1 reference
Arnold M
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference